NeuroVisual Medicine Institute

What NeuroVisual Medicine Institute does

NeuroVisual Medicine Institute (legally Vision Specialists Institute, d/b/a NeuroVisual Medicine Institute) is a privately held healthcare training and clinical-protocol company headquartered in Bloomfield Hills, Michigan. It trains independent optometrists to become NeuroVisual Specialists capable of diagnosing and treating Binocular Vision Dysfunction (BVD) and Vertical Heterophoria (VH) — eye-misalignment conditions affecting an estimated 20% of the population that standard optometric testing routinely misses. The Institute was founded in 2011 by Dr. Debby Feinberg and Dr. Mark Rosner, building on Dr. Feinberg's pioneering BVD clinical work that began in 1995 at Vision Specialists of Michigan, which has treated more than 20,000 BVD/VH patients to date.

The core asset is the NeuroVisual Clinical Protocol — a codified, step-by-step methodology for screening (via the proprietary BVDQ questionnaire, completed by 50,000+ patients and validated in peer-reviewed literature), binocular vision evaluation, trial framing, and prescription of microprism lenses in increments as small as 0.25 diopters, optionally combined with noise-canceling devices for patients with comorbid Third Mobile Window Syndrome. The Institute delivers this through a 5-day in-person Masterclass backed by a 250+ page curriculum, a diagnostic equipment kit, bi-weekly clinical coaching, and monthly practice-growth coaching. There is no software or device manufacturing; the IP is the protocol, training content, and validated screening instrument.

Revenue is generated primarily from training-program tuition paid by optometry practices (with optional in-house financing) plus ongoing coaching, while downstream economic value accrues to the certified-provider network through medical-insurance-billed specialty exams ($515-$900+ per exam versus standard comprehensive exams) and optical capture (75%+ capture rate). The Institute operates a built-in patient referral network channeling the ~4 weekly BVDQ-matched leads per certified provider, alongside an MD referral channel drawing patients from ENTs, neurologists, neuro-ophthalmologists, physiatrists, and osteopaths. As of the source data, 70+ optometrists have been trained and 40+ practices operate under the NeuroVisual model across the United States, Canada, Australia, and Sweden.

Name

NeuroVisual Medicine Institute

Legal name

Vision Specialists Institute D.B.A. NeuroVisual Medicine Institute

Website

https://nvminstitute.org

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

NeuroVisual Medicine Institute trains independent optometrists in a proprietary protocol for diagnosing and treating Binocular Vision Dysfunction and Vertical Heterophoria using microprism lenses, serving a network of 40+ specialty practices across the US, Canada, Australia, and Sweden.

Ownership category

akta.pro rank

Product category

Optometric Specialty Training

NAICS

Offices of Optometrists (62132)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Ophthalmic Goods (3851), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Optometry Clinics (Primary Eye Care) (HLAKAKAB)

akta.pro secondary industries

Vision Therapy & Orthoptics (HLAKAKAM), Neuro-Ophthalmology (HLAKAKAH)

Keywords

• Optometric specialty training
• Binocular vision dysfunction
• Microprism lens therapy
• Clinical protocol certification
• Practice growth coaching

Headquarters

HQ city

Bloomfield Hills

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Others

Revenue model

1. Training Program Tuition: Optometrists pay tuition to attend the 5-day hands-on Masterclass training program led by founders Dr. Debby Feinberg and Dr. Mark Rosner. Training includes curriculum materials (250+ pages), hands-on clinical sessions with live BVD patients, diagnostic equipment kit, customizable templates, and access to clinical coaching. Financing is available through the Institute.
2. Clinical Services (via Provider Network): Certified NeuroVisual specialists provide BVD evaluations and microprism lens prescriptions to patients, billed through medical insurance. Practices report average revenue per exam ranging from $515 to $900+ (vs. standard comprehensive exams). Average practices earn over $200k/year working 1 day per week. Services are also offered as private-pay for non-covered services.
3. Optical / Precision Eyewear Sales: Life-changing microprism lens care creates high patient loyalty and optical capture rates. Practices report +75% capture rate and +30% second pair sales rate. Precision eyewear providing symptom relief drives ongoing optical revenue for practices.
4. Financing Program: The Institute offers financing programs to enable practices to add NeuroVisual Medicine without dealing with banks or credit unions. Practices who finance their investment earn 10x return on monthly payments within 2-3 months of starting.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels9 records

Core offering

NeuroVisual Medicine Institute trains and certifies independent optometrists in a proprietary clinical protocol for diagnosing and treating Binocular Vision Dysfunction (BVD) and Vertical Heterophoria (VH) using microprism lenses. The Institute delivers a 5-day hands-on Masterclass, ongoing clinical and practice growth coaching, and equips certified providers with screening tools, diagnostic protocols, and a built-in patient referral network to deliver BVD evaluations and treatment.

Product overview

NeuroVisual Medicine Institute offers a specialized clinical specialty and training platform for optometrists to diagnose and treat Binocular Vision Dysfunction (BVD) and Vertical Heterophoria (VH). The core offering is the NeuroVisual™ Clinical Protocol—a step-by-step approach using microprism lenses that delivers up to 80% symptom reduction. The company provides the NeuroVisual™ Training Program (including a 5-day hands-on masterclass and clinical coaching), diagnostic tools (BVDQ™ questionnaire, 5-Minute Cover Test™), and access to a network of certified NeuroVisual specialists. Treatment products include microprism lenses and noise-canceling devices. The business model combines medical billing guidance, practice growth support, and an integrated patient referral network for member practices.

Differentiator

Problem solved

Functional benefit

Products and services

• NeuroVisual Training Program A comprehensive optometrist certification program that teaches the NeuroVisual Clinical Protocol for diagnosing and treating Binocular Vision Dysfunction (BVD) and Vertical Heterophoria (VH) using microprism lenses. The program targets independent optometrists seeking to add a high-margin specialty service line.
• 5-Day Hands-on Masterclass In-person intensive training week delivered by the founders (Dr. Debby Feinberg and Dr. Mark Rosner) at the Institute's training facility, providing clinicians with hands-on practice on live BVD patients.
• Clinical Coaching Program Ongoing bi-weekly coaching sessions with NeuroVisual clinical faculty where certified optometrists review patient cases and receive guidance on prescription refinement and patient care.
• Practice Growth Coaching Monthly business coaching program with practice growth coaches covering goal setting, progress check-ins, and operational support to help practices scale NeuroVisual Medicine from a half-day per week specialty to a full specialty practice.
• BVDQ (Binocular Vision Dysfunction Questionnaire) A scientifically validated downloadable screening questionnaire that identifies patients likely to have Vertical Heterophoria and respond to microprism treatment. Has been completed by over 50,000 patients worldwide and is available as a downloadable tool for clinicians.
• 5-Minute Cover Test A proprietary downloadable step-by-step screening test that can be performed at home or in clinical settings to identify candidates for NeuroVisual evaluation by demonstrating symptom relief when vision is made monocular.

Quantifiable outcome

• 80% reduction in BVD symptoms with microprism lenses (based on n=126 patients in NeuroVisual Medicine Institute Study)
• +12 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Otolaryngologists (ENTs)coreStrategic or Co-development PartnerENT physicians regularly refer patients with dizziness, vestibular symptoms, and post-concussion symptoms to NeuroVisual specialists for evaluation of comorbid BVD. Dr. Arthur Rosner (ENT) has firsthand knowledge of the dizzy community and refers hundreds of patients for NeuroVisual evaluation after relieving his own BVD symptoms with microprisms.
• Neuro-OphthalmologistscoreStrategic or Co-development PartnerNeuro-ophthalmologists like Dr. David Blodgett regularly refer patients with subtle eye misalignments (too small for surgery) to NeuroVisual certified optometrists for microprism treatment. Larger misalignments are handled surgically, while small misalignments are sent for NeuroVisual care.
• NeurologistscoreStrategic or Co-development PartnerNeurologists, particularly those specializing in traumatic brain injury (TBI), refer complex patients for NeuroVisual evaluation. Dr. Randall Benson, a behavioral neurologist and imaging neuroscientist, refers his most complex TBI patients and reports that as many as half of his TBI patients have BVD.
• Clinical PsychologistsminorStrategic or Co-development PartnerClinical psychologists screen patients with symptoms such as anxiety, learning difficulty, ADHD, and motion sickness for BVD as an initial step to identify underlying binocular vision issues contributing to psychological symptoms. Dr. Aaron Goldner regularly fields these patients and refers for NeuroVisual evaluation.
• Osteopaths and PhysiatristsminorStrategic or Co-development PartnerOsteopathic physicians (Dr. Jay Sandweiss) and physiatrists (Dr. Jennifer Doble) who treat chronic headaches, dizziness, and neck pain refer refractory patients for NeuroVisual evaluation. Dr. Doble has treated thousands of TBI patients and considers BVD treatment a crucial component of their care.
• Vision Specialists of MichigancoreStrategic or Co-development PartnerThe original clinical practice where Dr. Debby Feinberg treated her first BVD patients in 1995 and has since treated 20,000+ BVD/VH patients. This practice serves as the clinical model for the training program and the site of the founding clinical research.
• NeuroVisual Network of OptometristscoreStrategic or Co-development Partner40+ independent optometry practices worldwide that have adopted the NeuroVisual Medicine business model and completed the training program. These practices form the NeuroVisual Network, meeting virtually throughout the year to discuss challenges and opportunities, and sharing a private online network of NeuroVisual colleagues.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• EssilorLuxottica: EssilorLuxottica is the dominant ophthalmic lens and equipment company with comprehensive OD training and education programs. Comparable as a broad incumbent that supplies lenses, training, and practice tools to optometrists across multiple specialty tracks including advanced lens designs.
• Hoya Vision Care: Hoya Vision Care is a large ophthalmic lens and education company that offers practitioner training programs and lens solutions to independent optometrists. Comparable as an established player that supports optometry specialization with branded lens products, ongoing education, and practice support.
• Bausch + Lomb: Bausch + Lomb manufactures ophthalmic lenses, contact lenses, and vision-care products and runs training initiatives for eye care professionals. Comparable as a broad incumbent with the reach and clinical relationships to enter BVD-adjacent specialty markets.

Direct peers

• Neuro-Optometric Rehabilitation Association (NORA): NORA certifies optometrists in neuro-optometric rehabilitation, including TBI/concussion-related binocular vision care. Comparable because it serves as an alternative credentialing pathway for optometrists seeking to specialize in the same TBI/vestibular-adjacent patient population NVMI addresses.
• College of Syntonic Optometry: College of Syntonic Optometry certifies optometrists in syntonic phototherapy, an optometric specialty. It is comparable as a specialty-track certification body that trains optometrists on a specific clinical methodology with practice-economics appeal similar to NVMI's microprism protocol.
• College of Optometrists in Vision Development (COVD): COVD is the leading optometric body certifying doctors in vision therapy and binocular vision, including specialties closely related to BVD. It is comparable as it delivers specialty education and certification to optometrists treating binocular/oculomotor conditions.
• Neurolens (EyeBrain Medical): Neurolens sells contoured microprism lenses and trains optometrists to use them for similar symptom clusters (headaches, dizziness, eye strain). It is the most direct competitor to NeuroVisual in the microprism-for-BVD category, targeting the same optometry channel with claims of comparable symptom relief.
• Optometric Extension Program Foundation (OEPF): OEPF delivers continuing education and clinical curriculum for optometrists focused on vision therapy and behavioral optometry. It overlaps with NVMI's training-program function for ODs wanting to expand beyond refractive care.

Emerging players

• SightSync (Concussion Health / Bioness-style TBI visual training programs): SightSync offers neuro-visual training software and assessment tools used by optometrists and rehab specialists treating concussion-related vision dysfunction. Comparable as a more software-centric emerging entrant addressing the same TBI/BVD patient population with a different delivery model.

Others

• Bernell Vision: Bernell Vision is a long-standing distributor of optometric and vision therapy tools, lenses, prisms, and training materials. Comparable as an ecosystem supplier that supports vision therapy and binocular vision specialty practices that overlap with NVMI-trained providers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/neurovisual-medicine-institute
• Facebookfacebook.com/nvminstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeuroVisual Medicine Institute